Woman clutching her abdomen with a highlighted illustration of the liver, symbolizing liver-related health issues, representing Chemomab Therapeutics.

#CMMB dips 8% despite FDA feedback clearing key hurdles for Phase 3 of nebokitug in primary sclerosing cholangitis. Regulatory path is now streamlined, and partnering discussions are underway.
#ChemomabTx
prismmarketview.com/chemomab-adv...